Cohort study of Patients with metastatic colorectal cancer Treated by XELOX with bevacizumab
收藏NIAID Data Ecosystem2026-03-06 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2620339
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: 1)Capecitabine at a dose of 2,000mg/m2/day orally in 2 divided doses for 2weeks on and 1week rest 2) tri-Weekly oxaliplatin at a dose of 130mg/m2 intravenously 3) tri-weekly bevacizumab at a dose of 5mg/kg intravenously
Primary outcome(s): Frequency and Degree of Hand-foot symdrome(HFS),Neuropathy and Vascular disorders
Study Design: Single arm Non-randomized
创建时间：
2011-01-15
